Clinical Trials Browser

Phase 1/2 × Colorectal Neoplasms × Sunitinib × Clear all

NCT00361244 2017-02-17

SU011248 in Combination With Irinotecan and Cetuximab as a Second Line Regimen for Stage IV Colorectal Cancer

Phase 1/2 Terminated

Gastrointestinal

Colorectal Neoplasms